 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics, Inc. NASDAQ: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will participate in a fireside chat at SVB Leerinks 3rd Annual CNS Forum on June 29th at 4:15pm ET. A live webcast of each presentation can be accessed on the investor page of Sages website at investor.sagerx.com. A replay of t 